Why some family offices are becoming cancer research’s new bankrollers

March 13, 2026 | Marcus Baram

Family offices are stepping in to fill a widening gap in cancer research funding, deploying billions of dollars of patient capital at a moment when federal cuts threaten to stall laboratories and AI breakthroughs promise to accelerate drug development.

Read More at Crain Currency.

UPDATES ANDΒ NEWS

Insights & Updates

Breaking Through Pancreatic Cancer with Revolution Medicines

Media Coverage

Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative | The ASCO Post

Press Release

At a Turning Point for RAS-directed Therapies, Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative

Media Coverage

How scientists found a weakness in one of the deadliest β€˜undruggable’ cancers | The Washington Post

View All

BE PART OF THE MISSION
Stay Informed, Make an Impact

Subscribe

Be the first to hear about cutting-edge research, pioneering projects, and the latest advancements in Break Through Cancer science. Sign up to stay informed.

* indicates required
Email Format

Give

Your contribution fuels groundbreaking research in some of the most challenging cancers. Every gift accelerates progress. For more information please contact Michaela Forand at MF@breakthroughcancer.org or 1-800-757-9881 ext 2.

Media Coverage
6 likes